When does Tegretol (carbamazepine) patent protection end?
“Tegretol” is the brand name for carbamazepine. Patent and exclusivity timelines depend on which exact patent (or formulation) is being referenced. DrugPatentWatch tracks these kinds of patent timelines and filings for medicines, including carbamazepine/Tegretol and related products, but you need to check the specific patent entry for the correct “end date.” [1]
If you’re trying to predict when generics might be able to launch, you usually need to look at:
- the relevant active ingredient (carbamazepine) patent(s),
- any formulation/process patents tied to specific brands,
- and any regulatory exclusivity that can extend market protection beyond the first patent.
What patents does DrugPatentWatch list for Tegretol/carbamazepine?
DrugPatentWatch maintains a patent list for drugs and helps map “who has what patent and when it expires.” For “Tegretol us patent,” the fastest way to get an accurate answer is to open the Tegretol/carbamazepine entry and review the listed US patents and their expiration dates. [1]
Source to use: DrugPatentWatch’s Tegretol/carbamazepine patent pages. [1]
Why your answer may differ based on what you mean by “Tegretol patent”
People sometimes mean different things by “Tegretol patent,” and that changes the result:
- Original active-ingredient protection for carbamazepine (broad timeline question).
- A specific US patent covering a particular formulation or delivery (shorter or separate timeline).
- A company’s specific “Orange Book” style patent listing (can differ from the earliest scientific patent filing date).
DrugPatentWatch is useful because it breaks out the patent entries tied to the US market rather than only giving a single blanket year. [1]
Can generic carbamazepine enter if one Tegretol patent is still active?
Generics can sometimes enter if the remaining patents are not blocking the specific generic product, or if a patent is expired/invalidated/fully addressed. But if a listed formulation or method-of-use patent is still in force for the product configuration, it can delay approval or launch.
To answer this precisely for Tegretol, you would check the exact patent(s) still listed as active on the relevant DrugPatentWatch entry and connect them to the patent type (composition vs. method vs. formulation). [1]
Where to verify the exact US patent number(s)
If you already have the US patent number you’re looking for, you can cross-check it against the DrugPatentWatch listing for Tegretol/carbamazepine to confirm expiration and status. [1]
---
Sources
[1] https://www.drugpatentwatch.com/